Total Credits: 1 including 1 AOA Category 1-A Credit(s)
In the past few years, a number of medications have been introduced that lower the risk of cardiovascular disease in patients with diabetes. Previously, cardiovascular risk reduction was not correlated with A1c. Now there are new tools to reduce cardiovascular risk in those with diabetes. This lecture will review strategies to provide patients with diabetes with the greatest cardiovascular risk reduction.
Learning Objectives:
1. Discuss the most recent medications that provide cardiovascular protection in patients with diabetes
2. Describe lifestyle changes to affect cardiovascular risk in patients with diabetes
3. Provide a recommendation on when and how to use medications to reduce the risk of cardiovascular disease in patients with diabetes
Disclosures: None Reported
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Osteopathic Physicians and Surgeons of California (OPSC) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
Grievance Policy: OPSC strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to OPSC, by calling the OPSC Office at 916-822-5246 or by email to opsc@opsc.org.
Dr. Kim Pfotenhauer is an Assistant Professor and the Director of Clerkship Curriculum at Michigan State College of Osteopathic Medicine (MSUCOM), East Lansing, Michigan. Previously, she was an Assistant Professor at Touro University College of Osteopathic Medicine (TUCOM), Vallejo, California. Dr. Pfotenhauer is board certified in Family Medicine and Osteopathic Manipulative Therapy by the American Board of Family Physicians. She is also board certified in Advanced Diabetes Management by the Association of Diabetes Care and Education Specialists. Dr. Pfotenhauer recently became a fellow of the American College of Osteopathic Family Physicians.
Dr. Pfotenhauer completed her Doctor of Osteopathic Medicine degree at MSU-COM in 2009 and then completed a fellowship in Diabetology at TU-COM in 2019. She serves on the American Diabetes Association Women's Interprofessional Network Advisory Group and as National Faculty for the National Board of Osteopathic Medical Examiners (NBOME). Speaking regionally and nationally on diabetes, nonalcoholic fatty liver disease, and vitamin D, she focuses on empowering primary care physicians to improve patient metabolic health.
Kim Pfotenhauer, DO, discloses that she has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|